+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Organ Transplant Immunosuppressant Drugs Market Size, Share & Trends Analysis Report By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents), By Transplant Type, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032375
Description Jump to:
The global organ transplant immunosuppressant drugs market size is estimated to reach USD 7.24 billion by 2030, registering a CAGR of 4.7% from 2025 to 2030. Growing patient population requiring organ transplantations and increasing approval of novel products are the factors driving the market growth. However, the high procedural cost of transplantations, the disproportion in the supply and demand for organs, and uncertain reimbursement scenario are the major factors restraining the market growth.

According to the Health Resources & Services Administration and the U.S. Department of Health and Human Services, more than 113,000 people were in need of transplants as of January 2019 and 36,528 transplants were performed in 2018. Hence, there is huge demand for organ transplants that will further boost the market. Kidney transplant held the largest market share in the transplant segment and is expected to retain its leading position through the forecast period. This can be attributed to increasing demand and comparatively better availability of kidneys than other organs.

Among the drug classes, the calcineurin inhibitors are expected to dominate the global organ transplant immunosuppressant drugs market through the forecast period. There are two drugs in this drug class, Prograf (tacrolimus) and Neoral/Sandimmune (cyclosporine). Although these effective immunosuppressants have been used in kidney transplant recipients for more than 20 years, they hold extensive toxicity profiles. Asia Pacific is expected to show the highest CAGR, while North America is expected to hold the largest share during the forecast period.

Organ Transplant Immunosuppressant Drugs Market Report Highlights

  • Calcineurin inhibitors are expected to command the largest market share in the drug class segment. Calcineurin inhibitors inhibit the activation action of T-cells of the immune system by the enzyme calcineurin.
  • Calcineurin inhibitors such as tacrolimus and cyclosporine are the cornerstone of immunosuppression for kidney transplantation. In more than 85% cases of kidney transplant, tacrolimus is prescribed as a part of the patients’ maintenance immunosuppressive regimen.
  • Based on transplant type, the kidney transplant held the largest market share of 49.1% in 2024, due to the increasing demand for kidney replacement procedures
  • Asia Pacific regional market is expected to demonstrate the fastest growth over the forecast period due to rising per capita healthcare expenditure, improving healthcare infrastructure, and increasing demand for organ transplantations in the region.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Transplant Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Organ Transplant Immunosuppressant Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Organ Transplant Immunosuppressant Drugs Market: Drug Class Business Analysis
4.1. Drug Class Market Share, 2024 & 2030
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
4.4. Calcineurin Inhibitors
4.4.1. Calcineurin Inhibitors Market, 2018 - 2030 (USD Million)
4.5. Antiproliferative Agents
4.5.1. Antiproliferative Agents Market, 2018 - 2030 (USD Million)
4.6. mTOR Inhibitor
4.6.1. mTOR Inhibitor Market, 2018 - 2030 (USD Million)
4.7. Steroids
4.7.1. Steroids Market, 2018 - 2030 (USD Million)
4.8. Other Drug Classes
4.8.1. Other Drug Classes Market, 2018 - 2030 (USD Million)
Chapter 5. Organ Transplant Immunosuppressant Drugs Market: Transplant Type Business Analysis
5.1. Transplant Type Market Share, 2024 & 2030
5.2. Transplant Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Transplant Type, 2018 to 2030 (USD Million)
5.4. Kidney
5.4.1. Kidney Market, 2018 - 2030 (USD Million)
5.5. Liver
5.5.1. Liver Market, 2018 - 2030 (USD Million)
5.6. Heart
5.6.1. Heart Market, 2018 - 2030 (USD Million)
5.7. Lung
5.7.1. Lung Market, 2018 - 2030 (USD Million)
5.8. Pancreas
5.8.1. Pancreas Market, 2018 - 2030 (USD Million)
5.9. Other Transplant Types
5.9.1. Other Transplant Types Market, 2018 - 2030 (USD Million)
Chapter 6. Organ Transplant Immunosuppressant Drugs Market: Regional Estimates & Trend Analysis by Drug Class and Transplant Type
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. Australia Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. South Korea Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Organ Transplant Immunosuppressant Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Astellas Pharma d.o.o.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Sanofi
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Accord Healthcare
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Novartis AG
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Viatris Inc.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. F. Hoffmann-La Roche Ltd
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. GlaxoSmithKline plc.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Veloxis Pharmaceuticals, Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Bristol-Myers Squibb Company
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global organ transplant immunosuppressant drugs market, by region, 2018 - 2030 (USD Million)
Table 4. Global organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 5. Global organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 6. North America organ transplant immunosuppressant drugs market, by country, 2018 - 2030 (USD Million)
Table 7. North America organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 8. North America organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 9. U.S. organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 10. U.S. organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 11. Canada organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 12. Canada organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 13. Mexico organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 14. Mexico organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 15. Europe organ transplant immunosuppressant drugs market, by country, 2018 - 2030 (USD Million)
Table 16. Europe organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 17. Europe organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 18. UK organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 19. UK organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 20. Germany organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 21. Germany organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 22. France organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 23. France organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 24. Italy organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 25. Italy organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 26. Spain organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 27. Spain organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 28. Denmark organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 29. Denmark organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 30. Sweden organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 31. Sweden organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 32. Norway organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 33. Norway organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 34. Asia Pacific organ transplant immunosuppressant drugs market, by country, 2018 - 2030 (USD Million)
Table 35. Asia Pacific organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 36. Asia Pacific organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 37. Japan organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 38. Japan organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 39. China organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 40. China organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 41. India organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 42. India organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 43. Australia organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 44. Australia organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 45. South Korea organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 46. South Korea organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 47. Thailand organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 48. Thailand organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 49. Latin America organ transplant immunosuppressant drugs market, by country, 2018 - 2030 (USD Million)
Table 50. Latin America organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 51. Latin America organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 52. Brazil organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 53. Brazil organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 54. Argentina organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 55. Argentina organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa Organ transplant immunosuppressant drugs market, by country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 59. South Africa organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 60. South Africa organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 63. UAE organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 64. UAE organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
Table 65. Kuwait organ transplant immunosuppressant drugs market, by drug class, 2018 - 2030 (USD Million)
Table 66. Kuwait organ transplant immunosuppressant drugs market, by transplant type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Organ transplant immunosuppressant drugs market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Drug class and transplant type outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Organ transplant immunosuppressant drugs market dynamics
Fig. 12 Organ transplant immunosuppressant drugs market: Porter’s five forces analysis
Fig. 13 Organ transplant immunosuppressant drugs market: PESTLE analysis
Fig. 14 Organ transplant immunosuppressant drugs market: Drug class segment dashboard
Fig. 15 Organ transplant immunosuppressant drugs market: Drug class market share analysis, 2024 & 2030
Fig. 16 Calcineurin inhibitors market, 2018 - 2030 (USD Million)
Fig. 17 Antiproliferative agents market, 2018 - 2030 (USD Million)
Fig. 18 mTOR inhibitor market, 2018 - 2030 (USD Million)
Fig. 19 Steroids market, 2018 - 2030 (USD Million)
Fig. 20 Other drug classes market, 2018 - 2030 (USD Million)
Fig. 21 Organ transplant immunosuppressant drugs market: Transplant type segment dashboard
Fig. 22 Organ transplant immunosuppressant drugs market: Transplant type market share analysis, 2024 & 2030
Fig. 23 Kidney market, 2018 - 2030 (USD Million)
Fig. 24 Liver market, 2018 - 2030 (USD Million)
Fig. 25 Heart market, 2018 - 2030 (USD Million)
Fig. 26 Lung market, 2018 - 2030 (USD Million)
Fig. 27 Pancreas market, 2018 - 2030 (USD Million)
Fig. 28 Other transplant types market, 2018 - 2030 (USD Million)
Fig. 29 Organ transplant immunosuppressant drugs market revenue, by region
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 North America organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 33 US country dynamics
Fig. 34 US organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 35 Canada country dynamics
Fig. 36 Canada organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 37 Mexico country dynamics
Fig. 38 Mexico organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 39 Europe organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 40 UK country dynamics
Fig. 41 UK organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 42 Germany country dynamics
Fig. 43 Germany organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 44 France country dynamics
Fig. 45 France organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 46 Italy country dynamics
Fig. 47 Italy organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 48 Spain country dynamics
Fig. 49 Spain organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 50 Denmark country dynamics
Fig. 51 Denmark organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 52 Sweden country dynamics
Fig. 53 Sweden organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 54 Norway country dynamics
Fig. 55 Norway organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 57 Japan country dynamics
Fig. 58 Japan organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 59 China country dynamics
Fig. 60 China organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 61 India country dynamics
Fig. 62 India organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 63 Australia country dynamics
Fig. 64 Australia organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 65 South Korea country dynamics
Fig. 66 South Korea organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 67 Thailand country dynamics
Fig. 68 Thailand organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 69 Latin America organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 70 Brazil country dynamics
Fig. 71 Brazil organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 72 Argentina country dynamics
Fig. 73 Argentina organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 74 MEA organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 75 South Africa country dynamics
Fig. 76 South Africa organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 77 Saudi Arabia country dynamics
Fig. 78 Saudi Arabia organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 79 UAE country dynamics
Fig. 80 UAE organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 81 Kuwait country dynamics
Fig. 82 Kuwait organ transplant immunosuppressant drugs market, 2018 - 2030 (USD Million)
Fig. 83 Company categorization
Fig. 84 Company market position analysis
Fig. 85 Strategic framework

Companies Mentioned

  • Astellas Pharma d.o.o.
  • Sanofi
  • Accord Healthcare
  • Novartis AG
  • Viatris Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Veloxis Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.24 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Organ Transplant Immunosuppressant Drugs Market by Drug Class, Transplant Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Organ Transplant Immunosuppressant Drugs Market by Drug Class, Transplant Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report - Product Image

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Global Market Report 2024 - Product Image

Organ Transplant Immunosuppressant Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Japan Immunosuppressant Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

Japan Immunosuppressant Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 80 Pages
  • Japan
From
Immunosuppressant Drugs Market by Function, Drug Class, Route of Administration, End User - Global Forecast 2025-2030 - Product Image

Immunosuppressant Drugs Market by Function, Drug Class, Route of Administration, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.